Who owns the CYBREXA THERAPEUTICS trademark?

The CYBREXA THERAPEUTICS trademark is owned by Cybrexa, Inc..

What class is the CYBREXA THERAPEUTICS trademark registered in?

The CYBREXA THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CYBREXA THERAPEUTICS?

The USPTO serial number for CYBREXA THERAPEUTICS is 87390727.

What is the registration number for CYBREXA THERAPEUTICS?

CYBREXA THERAPEUTICS is registered under USPTO registration number 6080446.

Sealvo

Home Search: CYBREXA THERAPEUTICSCYBREXA THERAPEUTICS #87390727

Back

Updated Oct 3, 2026·18 searches this week

View on USPTO TSDR Find similar marks

CYB

USPTO Trademark Record

REGISTERED

CYBREXA THERAPEUTICS

SN 87390727·Reg 6080446·Filed Mar 29, 2017

Owner Cybrexa, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CYBREXA THERAPEUTICS (Serial No. 87390727), Registration No. 6080446, is a registered US trademark filed on Mar 29, 2017 by Cybrexa, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: June 17, 2030

Conflict Analysis

Full conflict analysis for CYBREXA THERAPEUTICS (SN 87390727) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

CYBREXA THERAPEUTICS (Reg. #6080446) is a registered US trademark that has been protecting its owner, Cybrexa, Inc., since 2017. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 29, 2017

SERIAL

87390727

REG#

6080446

REGISTERED

Jun 16, 2020

Filing Information

StatusREGISTERED

Filing DateMar 29, 2017

Serial Number87390727

Registration No.6080446

Registration DateJun 16, 2020

Status DateNov 28, 2025

Published for OppositionJul 25, 2017

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlySection 8 AcceptedSection 15 Acknowledged

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jan 01, 2018

First use in commerce: Jan 01, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

53 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 28, 2025

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Nov 28, 2025

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Nov 28, 2025

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Aug 13, 2025

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 16, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Jun 16, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 12, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

May 11, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

May 11, 2020

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 11, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 11, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 07, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 21, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Apr 21, 2020

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Apr 21, 2020

NON-FINAL ACTION E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 19, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 18, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Mar 18, 2020

STATEMENT OF USE PROCESSING COMPLETE

SOU EXTENSION 5 GRANTED

Mar 18, 2020

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Mar 10, 2020

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

Mar 10, 2020

TEAS STATEMENT OF USE RECEIVED

SOU EXTENSION 5 FILED

Mar 10, 2020

SOU EXTENSION 5 FILED

USE AMENDMENT FILED

Mar 10, 2020

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 05, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 GRANTED

Sep 03, 2019

SOU EXTENSION 4 GRANTED

SOU EXTENSION 4 FILED

Sep 03, 2019

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Sep 03, 2019

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 21, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 19, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 GRANTED

Feb 19, 2019

SOU EXTENSION 3 GRANTED

SOU EXTENSION 3 FILED

Feb 19, 2019

SOU EXTENSION 3 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 13, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 11, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Sep 11, 2018

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Sep 11, 2018

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 15, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Mar 13, 2018

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Mar 13, 2018

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Mar 13, 2018

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 19, 2017

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 25, 2017

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 25, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 05, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jun 16, 2017

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Jun 07, 2017

ASSIGNED TO LIE

EXAMINER'S AMENDMENT ENTERED

Apr 28, 2017

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT E-MAILED

Apr 28, 2017

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 28, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 28, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Apr 28, 2017

EXAMINERS AMENDMENT -WRITTEN

ASSIGNED TO EXAMINER

Apr 21, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 04, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 01, 2017

NEW APPLICATION ENTERED

Other Marks by Cybrexa, Inc.

Additional USPTO filings from the same owner.

CYB

CYBREXA

87314496

Cybrexa, Inc.

REGISTERED

CYB

CYBREXA THERAPEUTICS

87390742

Cybrexa, Inc.

REGISTERED

ALP

ALPHALEX

97640497

Cybrexa, Inc.

PENDING

ALP

ALPHALEX

88197341

Cybrexa, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

CYB

CYBREXA THERAPEUTICS

87390742

Cybrexa, Inc.

REGISTERED

CYB

CYBREXA

87314496

Cybrexa, Inc.

REGISTERED

AVE

AVELOS THERAPEUTICS

97439188

Avelos Therapeutics, Inc.

REGISTERED

VEL

VELVET THERAPEUTICS

98405135

Twister Biotech Inc.

REGISTERED

Other Marks by Patricia A. Olosky

Additional USPTO filings handled by the same attorney of record.

THE

THE WORLD'S MOST IMPORTANT GATHERING OF CHROS AND HR EXECUTIVES

98721051

REGISTERED

TAL

TALENTNEURON

79181725

REGISTERED

HRS

HR SYMPOSIUM/XPO

98721040

REGISTERED

LOG

LogoMark

99569181

REGISTERED

CYBREXA THERAPEUTICS

Run a conflict check

Other Marks by Cybrexa, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Patricia A. Olosky

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company